01

ABBVIE

U.S.A

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-11-22

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

US Patent Number : 8173708

Drug Substance Claim :

Drug Product Claim :

Application Number : 206439

Patent Use Code : U-1641

Patent Use Description : MEMANTINE HCL/DONEPEZI...

Patent Expiration Date : 2025-11-22

Product Web Link

Corporate PDF

02

ABBVIE

U.S.A

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-11-22

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

US Patent Number : 8173708

Drug Substance Claim :

Drug Product Claim :

Application Number : 206439

Patent Use Code : U-1641

Patent Use Description : MEMANTINE HCL/DONEPEZI...

Patent Expiration Date : 2025-11-22

Product Web Link

Corporate PDF

03

ABBVIE

U.S.A

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-11-22

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

US Patent Number : 8362085

Drug Substance Claim :

Drug Product Claim :

Application Number : 206439

Patent Use Code : U-1641

Patent Use Description : MEMANTINE HCL/DONEPEZI...

Patent Expiration Date : 2025-11-22

Product Web Link

Corporate PDF

04

ABBVIE

U.S.A

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-24

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

US Patent Number : 8039009

Drug Substance Claim :

Drug Product Claim :

Application Number : 206439

Patent Use Code : U-1641

Patent Use Description : MEMANTINE HCL/DONEPEZI...

Patent Expiration Date : 2029-03-24

Product Web Link

Corporate PDF

05

ABBVIE

U.S.A

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-05

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

US Patent Number : 8058291

Drug Substance Claim :

Drug Product Claim :

Application Number : 206439

Patent Use Code : U-1641

Patent Use Description : MEMANTINE HCL/DONEPEZI...

Patent Expiration Date : 2029-12-05

Product Web Link

Corporate PDF

06

ABBVIE

U.S.A

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-11-22

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

US Patent Number : 8338486

Drug Substance Claim :

Drug Product Claim :

Application Number : 206439

Patent Use Code : U-1641

Patent Use Description : MEMANTINE HCL/DONEPEZI...

Patent Expiration Date : 2025-11-22

Product Web Link

Corporate PDF

07

ABBVIE

U.S.A

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-05

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

US Patent Number : 8058291

Drug Substance Claim :

Drug Product Claim :

Application Number : 206439

Patent Use Code : U-1641

Patent Use Description : MEMANTINE HCL/DONEPEZI...

Patent Expiration Date : 2029-12-05

Product Web Link

Corporate PDF

08

ABBVIE

U.S.A

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-11-22

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

US Patent Number : 8283379

Drug Substance Claim :

Drug Product Claim :

Application Number : 206439

Patent Use Code : U-1641

Patent Use Description : MEMANTINE HCL/DONEPEZI...

Patent Expiration Date : 2025-11-22

Product Web Link

Corporate PDF

09

ABBVIE

U.S.A

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-11-22

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

US Patent Number : 8338486

Drug Substance Claim :

Drug Product Claim :

Application Number : 206439

Patent Use Code : U-1641

Patent Use Description : MEMANTINE HCL/DONEPEZI...

Patent Expiration Date : 2025-11-22

Product Web Link

Corporate PDF

10

ABBVIE

U.S.A

Compamed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-11-22

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

US Patent Number : 8338486

Drug Substance Claim :

Drug Product Claim :

Application Number : 206439

Patent Use Code : U-1641

Patent Use Description : MEMANTINE HCL/DONEPEZI...

Patent Expiration Date : 2025-11-22

Product Web Link

Corporate PDF

Donepezil Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

74 API Suppliers

32 USDMF

11 CEP/COS

16 JDMF

23 EU WC

70 KDMF

22 NDC API

36 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

12 Drugs in Development

INTERMEDIATES

33 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

582 FDF Dossiers

99 FDA Orange Book

302 Europe

44 Canada

32 Australia

30 South Africa

75 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG

TABLET;ORAL - 5MG

TABLET, ORALLY DISINTEGRATING;ORAL - 10MG

TABLET, ORALLY DISINTEGRATING;ORAL - 5MG

TABLET;ORAL - 23MG

RELATED EXCIPIENT COMPANIES

1 Minakem

2 Evonik

5 Rochem International Inc

18 SPI Pharma

2 Seqens

20 DKSH

3 Jai Radhe Sales

2 Pharm-RX Chemical

8 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

15 Gangwal Healthcare

10 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 ACG Worldwide

8 Actylis

1 Aeon Procare

3 Alcedo Pharmachem

12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Avesta Pharma

35 BASF

1 Bioplus Life Sciences

2 Clariant

15 Corel Pharma Chem

6 DFE Pharma

2 Finar

13 Gangwal Chemicals

16 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

33 Kerry

4 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

1 Nanjing Bold Chemical

1 NEWEDGE Overseas

2 Nomisma Healthcare

4 Novo Excipients

5 Pharmatrans-Sanaq

8 Pluviaendo

5 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

21 Roquette

14 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical